Pharma’s reach for underserved patients

Biz Community covers the Access to Medicine Foundation’s latest report, which addresses how pharma companies are reaching people worldwide, especially in low- and middle-income countries (LMICs).

The article highlights the shortcomings in pharmaceutical companies’ efforts to expand access to essential medicines in LMICs, according to the new report released by the Foundation. It points out that despite increased demand, significant portions of these populations still struggle to obtain life-saving treatments.

It also outlines the report's recommendations for the industry, including improving transparency, refining patient access metrics, and collaborating with partners to collect more precise data on the ground. The article suggests that these actions are vital for making meaningful strides in global health equity.